Status:
UNKNOWN
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
Lead Sponsor:
Gynecologic Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Fallopian Tube Cancer
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
RATIONALE: Finding specific proteins in the blood may help doctors tell whether a patient has ovarian cancer. PURPOSE: This clinical trial is studying how well proteomic profiling works in diagnosing...
Detailed Description
OBJECTIVES: Primary * Generate and validate a serum proteomic profile that can predict the presence of invasive ovarian epithelial cancer using preoperative serum specimens obtained from patients un...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Abnormal pelvic mass by physical examination or imaging test
- Undiagnosed
- Planning to undergo surgical evaluation within the next 3 weeks
- PATIENT CHARACTERISTICS:
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- Negative pregnancy test
- PRIOR CONCURRENT THERAPY:
- Surgery
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00238342
Start Date
October 1 2005
Last Update
February 9 2010
Active Locations (107)
Enter a location and click search to find clinical trials sorted by distance.
1
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Birmingham, Alabama, United States, 35294
2
Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas, United States, 72703
3
Washington Regional Medical Center
Fayetteville, Arkansas, United States, 72703
4
Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States, 91505